Can we better predict which skin cancers will spread?
NCT ID NCT05695222
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 1,500 people with a common skin cancer called cutaneous squamous cell carcinoma. Most cases are cured with surgery, but a small number can spread and become dangerous. Researchers will compare current staging systems to see which best predicts poor outcomes, aiming to improve future patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr Emilia Peleva
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
Whipps Cross University Hospital
RECRUITINGLondon, E11 1NR, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy before surgery may cut skin cancer recurrence
- Scientists map metabolic shifts in skin cancer development
- Cancer-Killing virus shows promise in early trial for advanced tumors
- New drug IDP-001 takes on advanced cancers in early trial
- New combo therapy aims to shrink inoperable skin cancers
- Tiny needle patch takes aim at skin cancer